Lynn Walder, Founder & Principal of Executive Management Partners and now the Director of Partnerships Programming at LabCentral, shares her transition and passion for aiding startup entrepreneurs. After considering various options, Lynn chose to remain with LabCentral in a different capacity, taking on the Director of Partnerships and Programming role. In this position, she creates learning and development programs, specifically tailored for startup entrepreneurs. Her love for assisting first-time founders shines through, emphasizing the importance of nurturing science through a business lense. Explore more about Lynn's impactful role in the full episode! ___________________________________________________________ Building Biotechs is a podcast by Recruitomics Consulting https://www.recruitomics.com/buildingbiotechspodcast Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders. Check out the full episode: https://buildingbiotechspodcast.com/episode/52 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

In this episode, I had an engaging conversation with Stacie Frye, Co-Founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs. Check out the full episode: https://buildingbiotechspodcast.com/episode/51 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups. Check out the full episode: https://buildingbiotechspodcast.com/episode/54/ ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

In this episode, Mike LaRhette, Chief Business Officer at LabCentral discusses how LabCentral helps startups navigate the transition from LabCentral to independent spaces. LabCentral aids startups in finding suitable new spaces, whether it's a natural progression to another LabCentral facility, partnering with other lab-sharing facilities, or finding a place of their own. The goal is to provide ongoing support beyond residency, fostering a seamless transition for startups. Discover more insights on the full episode! ___________________________________________________________ Building Biotechs is a podcast by Recruitomics Consulting https://www.recruitomics.com/buildingbiotechspodcast Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq

This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups. Connect with Russ on LinkedIn! https://www.linkedin.com/in/russ-peloquin/ Learn more about LifeSci Catalyst Partners! https://www.lifescicatalyst.com/ Get Russ's recommended book! Freakonomics: https://geni.us/3qZlQA _________________________________________________________________________ ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: [https://www.linkedin.com/company/building-biotechs-podcast/](https://www.linkedin.com/company/building-biotechs-podcast/?viewAsMember=true) 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com _________________________________________________________________________ 00:00 Introduction and Early Aspirations 02:04 Journey into Medical Sales 03:37 Marketing and Commercialization Insights 05:31 Navigating Early-Stage Startups 08:39 Fundraising Strategies for Biotech Startups 15:00 Acquisitions and Exits 22:39 The Intersection of Genome Sequencing, Blockchain, and AI 29:49 Future Goals and Recommendations 31:47 Closing Remarks and Contact Information

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success. Check out the full episode: https://buildingbiotechspodcast.com/episode/53 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders. Check out the full episode: https://buildingbiotechspodcast.com/episode/52 ✔️Subscribe to our Mailing List for weekly podcast drops and industry news (we promise no spam!) https://buildingbiotechs.beehiiv.com/ Follow us on Apple, Spotify, or wherever you love to listen. 👉 https://apple.co/3EDuZvA 👉 https://spoti.fi/48bs3nq Stay connected with us: 🌐 Website: https://buildingbiotechspodcast.com/ 💼 LinkedIn: https://www.linkedin.com/company/building-biotechs-podcast/ 🎙️Check out our sister podcast, Biotech Career Coach: https://biotechcareercoach.com/ Follow and Connect with Carina on LinkedIn: https://www.linkedin.com/in/cclingman/ In need of Fractional Talent Acquisition or Recruiting help? Reach out! info@recruitomics.com